Abstract
A multicentre noncomparative study of fluconazole in the treatment of systemic fungal infections was carried out in China in order to investigate the safety and efficacy of the drug. The results from five centres show that fluconazole is safe and convenient both intravenously and orally for systemic fungal infections such as candidosis and cryptococcosis. Good results were also obtained in patients with cryptococcal meningitis and there were encouraging results from the treatment of patients with chromoblastomycosis and fusariosis cutis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
